Search

The present work highlights the synthesis of graphene oxide (GO) modified polythiophene (PTh) for its application as an antibacterial agent as well as a visible light active photocatalyst. PTh was synthesized via the interfacial polymerization method using FeCl3 as initiator and then formulated as nanohybrids by mixing it in different weight ratios with graphene oxide (GO) i.e., 1 wt.%,3 wt.% and 5 wt. %. PTh and GO/PTh nanohybrids were characterized using FTIR, UV-visible, X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS) and scanning electron microscopy (SEM) techniques. The polymerization of PTh as well as modification of PTh with GO was confirmed by IR studies, while the shifting of electronic transitions of PTH upon modification with GO were confirmed by the UV-visible studies. The degradation of dyes, Alizarin Yellow (AY), Basic Blue (BB) and Congo Red (CR) was carried out via sonophotocatalysis under visible light using PTh and GO/PTh as catalysts for a period of 60 min. The GO/PTh revealed higher degradation efficiency as compared to PTh. To evaluate its effectiveness as an antibacterial agent against Bacillus subtilis, disk diffusion inhibitory assay was carried out under dark and light conditions. The results showed that PTh and GO/PTh nanohybrids had bactericidal properties, regardless of light exposure. The results of the minimal inhibitory concentration (MIC) assay indicated the nanohybrid of 3-GO/PTh had the lowest MIC, followed by 1-GO/PTh and 5-GO/PTh. [ABSTRACT FROM AUTHOR]

Carbon–semiconductor hybrid quantum dots are classical carbon dots with core carbon nanoparticles doped with a selected nanoscale semiconductor. Specifically, on those with the nanoscale TiO2 doping, denoted as CTiO2-Dots, their synthesis and thorough characterization were reported previously. In this work, the CTiO2-Dots were evaluated for their visible light-activated antibacterial function, with the results showing the effective killing of not only Gram-positive but also the generally more resistant Gram-negative bacteria. The hybrid dots are clearly more potent antibacterial agents than their neat carbon dot counterparts. Mechanistically, the higher antibacterial performance of the CTiO2-Dots is attributed to their superior photoexcited state properties, which are reflected by the observed much brighter fluorescence emissions. Also considered and discussed is the possibility of additional contributions to the antibacterial activities due to the photosensitization of the nanoscale TiO2 by its doped core carbon nanoparticles. [ABSTRACT FROM AUTHOR]

Carbon dots (CDots) are small carbon nanoparticles with effective surface passivation by organic functionalization. In the reported work, the surface functionalization of preexisting small carbon nanoparticles with N-ethylcarbazole (NEC) was achieved by the NEC radical addition. Due to the major difference in microwave absorption between the carbon nanoparticles and organic species such as NEC, the nanoparticles could be selectively heated via microwave irradiation to enable the hydrogen abstraction in NEC to generate NEC radicals, followed by in situ additions of the radicals to the nanoparticles. The resulting NEC-CDots were characterized by microscopy and spectroscopy techniques including quantitative proton and 13C NMR methods. The optical spectroscopic properties of the dot sample were found to be largely the same as those of CDots from other organic functionalization schemes. The high structural stability of NEC-CDots benefiting from the radical addition functionalization is highlighted and discussed. [ABSTRACT FROM AUTHOR]

The carbon/TiO2 hybrid dots (C/TiO2-Dots) are structurally TiO2 nanoparticles (in the order of 25 nm in diameter from commercially available colloidal TiO2 samples) surface-attached by nanoscale carbon domains with organic moieties, thus equivalent to hybrids of individual TiO2 nanoparticles each decorated with many carbon dots. These hybrid dots with exposure to visible light exhibit potent antibacterial properties, similar to those found in neat carbon dots with the same light activation. The results from the use of established scavengers for reactive oxygen species (ROS) to "quench" the antibacterial activities, an indication for shared mechanistic origins, are also similar. The findings in experiments on probing biological consequences of the antibacterial action suggest that the visible light-activated C/TiO2-Dots cause significant damage to the bacterial cell membrane, resulting in higher permeability, with the associated oxidative stress leading to lipid peroxidation, inhibiting bacterial growth. The induced bacterial cell damage could be observed more directly in the transmission electron microscopy (TEM) imaging. Opportunities for the further development of the hybrid dots platform for a variety of antibacterial applications are discussed. [ABSTRACT FROM AUTHOR]

Nitric oxide (NO)-mediated vasodilatation is a fundamental response of vasculature, however, regulation of NO signaling pathway on resistance vessels in the older adult with hypertension is still unclear. The 16-week-spontaneously hypertensive rats (SHR), the 18-month-SHR (OldSHR), and the age-matched Wistar-Kyoto rats were used to study the changes of mesenteric resistance artery dilatation caused by sodium nitroprusside (SNP). After pre-vasoconstriction by norepinephrine (NE), the response of endothelium-denuded mesenteric artery ring to SNP was observed, and the changes in vascular response after pharmacological interventions of key nodes in the NO/sGC/cGMP/PKG1α signaling pathway were observed as well. RNA sequencing and functional enrichment analyses were used to provide information for conducting validation experiments. Vasodilation of NO in OldSHR was decreased, which significantly correlated with the reduction of PKG-mediated effect. Functional enrichment analysis of RNA sequencing showed that genes encoding important proteins such as sGC and MYPT1 (protein phosphatase 1 regulatory subunit 12A) were downregulated in OldSHR. Molecular biology validation results showed that mRNA expression of both α and β subunits of sGC were reduced, while mRNA and protein expression of PKG1α were reduced in OldSHR. More importantly, the expression of MYPT1 and pS668-MYPT1 was significantly reduced in OldSHR, even under the treatment of SNP. The experiment also revealed an enhanced cAMP system in vasodilation in hypertension, while this function was completely lost in the OldSHR. Therefore, an NO-mediated decrease in vascular smooth muscle relaxation was found in the OldSHR. The dysfunction in cGMP-PKG signaling, in particular, decreased pS668-MYPT1 was mechanistically involved. [ABSTRACT FROM AUTHOR]

Remdesivir, an antiviral agent for the treatment of coronavirus disease 2019 (COVID‐19), is metabolized intracellularly, with these metabolites eliminated predominantly in urine. Because of a lack of safety and pharmacokinetic (PK) data, remdesivir is not currently recommended for patients with estimated glomerular filtration rate less than 30 ml/min/1.73 m2 and those on hemodialysis. This study evaluated the PKs of remdesivir and its metabolite, GS‐441524, in patients with COVID‐19 who were and were not receiving renal replacement therapy (RRT). This study enrolled two patients with normal renal function, two with impaired renal function not receiving RRT, two receiving continuous RRT (CRRT), and three undergoing intermittent hemodialysis (IHD). Patients were administered 200 mg remdesivir on the first day, followed by 100 mg/day for 5–10 days. Serial blood samples were collected for PK analysis, and PK parameters were assessed by a noncompartmental method. Systemic exposure to remdesivir was higher in patients with impaired renal function and those receiving CRRT than in patients with normal renal function, but was similar in patients undergoing IHD and those with normal renal function. By contrast, systemic exposure to GS‐441524 was highest in patients undergoing IHD, followed by patients with impaired renal function and those receiving CRRT, and lowest in patients with normal renal function. The PK profiles of remdesivir and GS‐441524 varied according to renal function and RRT. The impact of PK changes of remdesivir and its metabolite on safety and efficacy should be considered when administering remdesivir to patients with COVID‐19 with renal impairment. [ABSTRACT FROM AUTHOR]